Litigation Details for JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
✉ Email this page to a colleague
JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
Docket | ⤷ Try a Trial | Date Filed | 2018-01-17 |
Court | District Court, D. New Jersey | Date Terminated | |
Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
Jury Demand | None | Referred To | Mark Falk |
Patents | 9,439,906 | ||
Link to Docket | External link to docket |
Small Molecule Drugs cited in JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC.
Details for JANSSEN PHARMACEUTICALS, INC. v. TEVA PHARMACEUTICALS USA, INC. (D.N.J. 2018)
Date Filed | Document No. | Description | Snippet | Link To Document |
---|---|---|---|---|
2018-03-19 | 11 | an action for patent infringement of United States Patent No. 9,439,906 (the “’906 patent”). …an action for patent infringement of United States Patent No. 9,439,906 (the “’906 patent”) and that said…BACKGROUND 7. U.S. Patent No. 9,439,906 (the “’906 patent”) is entitled “Dosing Regimen …purports to state an action for patent infringement arising under the Patent Laws of the United States, 35… THE PATENT-IN-SUIT 29. Defendants admit that the face of the ’906 patent lists the | External link to document | |
>Date Filed | >Document No. | >Description | >Snippet | >Link To Document |